Ethos Financial Group, LLC
Source: SEC Form 13F · as of Mar 2026Ethos Financial Group, LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $13.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$13.9M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 11,034 | $2.5M |
| JNJJOHNSON & JOHNSON | 10,442 | $2.4M |
| LLYELI LILLY & Co | 2,174 | $2.1M |
| AMGNAMGEN INC | 3,070 | $1.1M |
| MRKMerck & Co., Inc. | 8,144 | $991K |
| PFEPFIZER INC | 29,945 | $778K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,893 | $512K |
| VKTXViking Therapeutics, Inc. | 14,012 | $493K |
| NVSNovartis AG | 2,986 | $456K |
| GILDGILEAD SCIENCES, INC. | 3,078 | $427K |
| ABTABBOTT LABORATORIES | 3,058 | $314K |
| PMPhilip Morris International Inc | 1,840 | $307K |
| MCKMcKesson Corporation | 322 | $279K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 507 | $226K |
| SUNSUNSET ISLAND GROUP | 4,142 | $217K |
| BMYBRISTOL MYERS SQUIBB CO | 3,432 | $211K |
| IQVIQVIA Holdings Inc. | 1,234 | $210K |
| CTMXCytomX Therapeutics, Inc. | 23,697 | $101K |
| CMPSCOMPASS Pathways plc | 13,532 | $93K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 23,486 | $72K |
| ORGOOrganogenesis Holdings Inc. | 12,987 | $67K |
| NRXPNRX Pharmaceuticals Inc. | 15,900 | $34K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.